dihydroergotamine mesylate
NDC 36000-300, dihydroergotamine mesylate, injection, solution, from Baxter Healthcare Corporation.
- Product NDC
- 36000-300
- Status
- Listed
- Labeler
- Baxter Healthcare Corporation
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216747
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/36000-300 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DIHYDROERGOTAMINE MESYLATE1 mg/mL
Pharmacologic classes
Ergotamine Derivative [EPC]; Ergotamines [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 36000-300-10 | 36000030010 | 10 AMPULE in 1 CARTON (36000-300-10) / 1 mL in 1 AMPULE (36000-300-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/f87dcd07-90ef-4e37-853e-7a5911a038b1
Use it
Look up 36000-300 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/36000-300 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 36000-300. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.